Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Market Cap	2.44B +61.5%
Revenue (ttm)	537.14M +8.4%
Net Income	804.00K -89.1%
EPS	0.04 -88.9%
Shares Out	20.80M
PE Ratio	3,039.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,048
Open	118.63
Previous Close	118.47
Day's Range	115.92 - 118.86
52-Week Range	70.84 - 147.00
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery t...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 348
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LOTUSEYE

Financial Performance

In fiscal year 2026, NSE:LOTUSEYE's revenue was 537.14 million, an increase of 8.38% compared to the previous year's 495.63 million. Earnings were 804,000, a decrease of -89.12%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error